UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036607
Receipt number R000041704
Scientific Title Effects of enteral nutrition with high-protein in critically ill patients
Date of disclosure of the study information 2019/04/26
Last modified on 2019/04/26 13:01:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of enteral nutrition with high-protein in critically ill patients

Acronym

Effects of enteral nutrition with high-protein in critically ill patients

Scientific Title

Effects of enteral nutrition with high-protein in critically ill patients

Scientific Title:Acronym

Effects of enteral nutrition with high-protein in critically ill patients

Region

Japan


Condition

Condition

Ventilated patients in the intensive care units

Classification by specialty

Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Comparison of effects of enteral nutrition with high-protein in critically ill patients with normal nutrition

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Serum prealbumin concentration 7,14,28 days after the beginning of the study

Key secondary outcomes

ventilator-free days,ICU length of stay,hospital length of stay,
SOFA score, serum albumin, white blood cell count, lymphocyte count, CRP, total cholesterol, urea nitrogen, creatinine 7,14,28 days after the beginning of the study,
total daily dose of insulin,
total energy, and protein dose during enteral nutrition
total amount of administration of blood products (albumin, globulin et al)
complications(vomiting, diarrhea, kidney injury, ventilator-associated pneumonia)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Peptamen Intense

Interventions/Control_2

Sanet N3

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)admission to the ICU
2)need for intubation and mechanical intubation
3)an expected duration of ventilation more than 6 days
4)unnecessary for a renal replacement therapy
5)patients with consent for included in the study

Key exclusion criteria

1)contraindication for enteral nutrient with high quantity of proteins
2)BMI more than 30, less than 18.5
3)denial of intensive care by a patients or a patient family
4)allergy to milk, soy, lactose
5)need for total parenteral nutrition
6)need for a renal replacement therapy
7)Patients judged as inappropriate to perform the present trial by the j the doctor

Target sample size

34


Research contact person

Name of lead principal investigator

1st name Hibiki
Middle name
Last name Serizawa

Organization

Osaka Saiseikai Senri Hospital

Division name

Senri Critical Care Medical Center

Zip code

565-0862

Address

1-1-6,Tsumkumodai,Suita-city,Osaka-fu

TEL

06-6871-0121

Email

webmaster_senri@senri.saiseikai.or.jp


Public contact

Name of contact person

1st name Hibiki
Middle name
Last name Serizawa

Organization

Osaka Saiseikai Senri Hospital

Division name

Senri Critical Care Medical Center

Zip code

565-0862

Address

1-1-6,Tsumkumodai,Suita-city,Osaka-fu

TEL

06-6871-0121

Homepage URL

http://www.senri.saiseikai.or.jp/hospital/department/trial/c_research/list.html

Email

webmaster_senri@senri.saiseikai.or.jp


Sponsor or person

Institute

Osaka Saiseikai Senri Hospital

Institute

Department

Personal name



Funding Source

Organization

Osaka Saiseikai Senri Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Saiseikai Senri Hospital institutional review board

Address

1-1-6,Tsumkumodai,Suita-city,Osaka-fu

Tel

06-6871-0121

Email

webmaster_senri@senri.saiseikai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2019 Year 03 Month 25 Day

Date of IRB


Anticipated trial start date

2019 Year 04 Month 27 Day

Last follow-up date

2020 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 04 Month 26 Day

Last modified on

2019 Year 04 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041704


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name